General Endocrinology

Members push aside data concerns, endorse retinoid for fibrodysplasia ossificans progressiva

Challenges of drug development in fibrodysplasia ossificans progressiva on full display

Tool is still useful, but should be used in concert with other measures, experts suggest

Some people just don't respond; others have such severe side effects they need to stop

These were patients with "really debilitating diabetes," says investigator

Warrior Labz SARMS markets several drugs they claim could address weight loss, muscle growth

Decreasing animal fat intake might reduce risks

Some more highlights from the Endocrine Society's annual meeting

The first step is "acknowledging it, supporting, and listening," researcher says

Men with hypogonadism and heart disease or risk factors saw no increased risk vs placebo

Metreleptin doses several times higher than recommended brought weight down to near normal

News and commentary from the endocrinology world

Rescheduling testosterone also under discussion at annual meeting

Association needs to move from passive support to proactive protection, delegate says